Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.12
+0.44 (3.77%)
Apr 28, 2025, 4:08 PM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
403.85417.66626.62466.45750.04
Short-Term Investments
-7.899.15106.98207.37
Trading Asset Securities
-8.498.2--
Cash & Short-Term Investments
403.85434.04643.97573.42957.41
Cash Growth
-6.96%-32.60%12.30%-40.11%-
Accounts Receivable
229.61142.38107.68103.0967.23
Other Receivables
-6.044.1714.9614.7
Receivables
229.61148.43111.85118.0581.93
Inventory
3.899.923.7321.6510.21
Other Current Assets
179.19130.69139.74161.1198.08
Total Current Assets
816.54723.05919.3874.241,148
Property, Plant & Equipment
1,3491,4511,5991,3911,136
Long-Term Investments
159.04241.24250.819.6910.09
Other Intangible Assets
20.6728.1330.656.062.43
Long-Term Deferred Tax Assets
0.96----
Other Long-Term Assets
68.636.16-21.8630.77
Total Assets
2,4152,4492,8002,3032,327
Accounts Payable
115.48175.23146.19102.4487.6
Accrued Expenses
-27.8951.6253.6627.41
Current Portion of Long-Term Debt
208.14176.84126.67--
Current Portion of Leases
17.8626.3644.9426.914.11
Current Income Taxes Payable
4.014.514.25.021.42
Current Unearned Revenue
102.1969.2256.3861.5847.51
Other Current Liabilities
87.2497.56176.06196.96150.42
Total Current Liabilities
534.91577.62606.05446.56328.47
Long-Term Debt
193.84173.9152.17--
Long-Term Leases
150.45167.01191.5162.966.81
Long-Term Unearned Revenue
84.987.0789.9392.890.12
Long-Term Deferred Tax Liabilities
-1.9---
Other Long-Term Liabilities
612.62651.48709.36448.55382.88
Total Liabilities
1,5771,6591,6491,051868.28
Common Stock
399.4399.4399.4374.93360
Additional Paid-In Capital
-1,9921,9921,5161,219
Retained Earnings
--1,787-1,404-802.32-256.75
Treasury Stock
--27.18-18.99--
Comprehensive Income & Other
434.66209.09178.32159.03130.69
Total Common Equity
834.06785.891,1461,2471,453
Minority Interest
4.554.554.554.764.83
Shareholders' Equity
838.6790.441,1511,2521,458
Total Liabilities & Equity
2,4152,4492,8002,3032,327
Total Debt
570.28544.11415.2889.880.92
Net Cash (Debt)
-166.43-110.07228.69483.62876.5
Net Cash Growth
---52.71%-44.82%-
Net Cash Per Share
-0.42-0.280.601.336.79
Filing Date Shares Outstanding
399.4399.4399.4396.69129.06
Total Common Shares Outstanding
399.4399.4399.4374.93129.06
Working Capital
281.62145.43313.25427.68819.17
Book Value Per Share
2.091.972.873.3311.26
Tangible Book Value
813.39757.761,1161,2411,451
Tangible Book Value Per Share
2.041.902.793.3111.24
Machinery
-1,4371,2081,107849.69
Construction In Progress
-5.19268.29181.96210.83
Leasehold Improvements
-240.53161.75166.4344.07
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.